Fresenius Kabi AG
Company Snapshot
Founded: 1912
Entity Type: Public
Employees: 40000
Region: Germany
Revenue: $8,662.3 Millions
Revenue Year: 2023
Headquarter: Bad Homburg , Germany
Key Geographics: Germany
Company Overview
Fresenius Kabi is one of four business segments of Fresenius SE & Co. KGaA, a European diversified healthcare company based in Bad Homburg, Germany. The Fresenius Group provides products and services for dialysis, hospitals, and inpatient and outpatient medical care. The company’s product offerings cater to various therapeutic areas, including oncology, diabetes, maldigestion, critical care, liver and renal insufficiency, pediatrics, and blood volume substitution. Fresenius is developing biosimilar products in the areas of immunology and oncology. The company’s R&D sites are in Europe, the U.S., and India, supported by a qualified research staff of 2,525 personnel.
Fresenius Kabi AG In News
Applications/End User Industries
- Hospitals
- Healthcare Professionals
- Oncology
- Long-Term Care Facilities
- Clinics
- Nephrology
- Pediatrics
- Geriatrics
- Surgery
- Enteral Nutrition
- Parenteral Nutrition
- Ambulatory
- Analgesia
- Anesthetics
- Critical Care Drugs
- Alternate Care Sites
- Research Labs
- Blood And Plasma Collection Centers
BCC Research Beacon 